Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1998-9-22
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0361-8609
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
59
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
101-2
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9723590-Adult,
pubmed-meshheading:9723590-Antineoplastic Agents,
pubmed-meshheading:9723590-Female,
pubmed-meshheading:9723590-Humans,
pubmed-meshheading:9723590-Interferon-alpha,
pubmed-meshheading:9723590-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:9723590-Pregnancy,
pubmed-meshheading:9723590-Pregnancy Complications, Neoplastic
|
pubmed:year |
1998
|
pubmed:articleTitle |
Interferon-alpha therapy for chronic myelogenous leukemia during pregnancy.
|
pubmed:publicationType |
Letter,
Case Reports
|